CMS Sterilization Policy (NCD 13) Updated for 2026: What Billing Teams Need to Know
CMS has modified its National Coverage Determination for sterilization procedures, policy code NCD 13, effective March 12, 2026. This update reinforces long-standing Medicare coverage rules distinguishing medically necessary sterilization from elective procedures—a distinction that directly affects claim outcomes for gynecology, urology, and general surgery practices billing into Medicare. If your team submits claims for hysterectomy, oophorectomy, orchidectomy, tubal ligation, or vasectomy on Medicare beneficiaries, this policy governs what gets paid and what gets denied.
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Sterilization |
| Policy Code | NCD 13 |
| Change Type | Modified |
| Effective Date | 2026-03-12 |
| Impact Level | Medium |
| Specialties Affected | Gynecology, Urology, General Surgery, Oncology |
| Key Action | Audit claims for sterilization-adjacent procedures to confirm documented pathological evidence supports medical necessity, not sterilization as the primary intent. |
CMS Medicare Sterilization Coverage Policy: The Core Rule
The Centers for Medicare & Medicaid Services operates under a foundational principle when it comes to sterilization: Medicare does not pay for procedures whose primary purpose is to prevent pregnancy or conception. This is not a gray area. The authority for this exclusion comes directly from §1862(a)(1) of the Social Security Act, which limits Medicare coverage to services that are reasonable and necessary for the diagnosis or treatment of illness or injury.
The practical implication for billing teams is that the same surgical procedure—say, a bilateral oophorectomy—can be covered or non-covered depending entirely on the documented clinical indication. The code doesn't determine coverage. The documented intent does.
What CMS Covers Under NCD 13: Medically Necessary Sterilization
CMS will pay for sterilization procedures when they are a necessary component of treating a diagnosed illness or injury. The policy provides two clear clinical examples:
| # | Covered Indication |
|---|---|
| 1 | Removal of a uterus (hysterectomy) performed because of a tumor |
| 2 | Removal of diseased ovaries (oophorectomy) due to pathological disease |
The policy also extends coverage to procedures performed on Medicare beneficiaries who have intellectual or developmental disabilities, but only under the same medical necessity framework. The specific example cited is bilateral oophorectomy or bilateral orchidectomy performed in the treatment of prostate cancer.
This is a critical nuance for oncology and urology billing teams. A bilateral orchidectomy for prostate cancer management is a covered service under NCD 13 when the pathological evidence supports cancer treatment as the indication.
What CMS Does Not Cover: Elective and Contraceptive Sterilization
The non-covered conditions under NCD 13 are explicitly defined and billing teams should treat this list as a hard denial trigger:
Nationally non-covered procedures when performed primarily for sterilization:
- Elective hysterectomy
- Tubal ligation
- Vasectomy
The policy goes further in defining two additional non-coverage scenarios that often catch practices off guard:
General health risk argument: A sterilization performed because a physician believes another pregnancy would endanger a patient's overall general health does not meet the "reasonable and necessary" threshold under Medicare. This is explicitly excluded—even with a physician's documented clinical concern.
Mental health prevention argument: Sterilization performed solely to prevent the possible development of, or effect on, a mental condition if the individual were to become pregnant is also non-covered. This applies whether the patient has a diagnosed psychiatric condition or not.
Contraceptive sterilization for individuals with intellectual disabilities: Sterilization of a beneficiary with intellectual or developmental disabilities is non-covered when the purpose is to prevent conception rather than to treat an illness or injury.
These exclusions matter because they represent scenarios where a physician may have genuine clinical reasoning—but that reasoning doesn't satisfy Medicare's statutory definition of medical necessity.
How CMS Expects Medicare Administrative Contractors to Handle These Claims
NCD 13 gives Medicare Administrative Contractors (MACs) specific claims handling instructions that your billing team should understand:
- MACs are directed to deny claims when pathological evidence of necessity to perform procedures for illness or injury treatment is absent.
- MACs are directed to monitor these surgeries closely and obtain the information needed to determine whether surgery was performed to treat an illness or injury, or solely to achieve sterilization.
This means your documentation cannot be vague. If you're billing a hysterectomy for fibroid tumor treatment on a Medicare patient, the pathology report and the operative notes need to clearly support that clinical indication. A diagnosis code for a tumor must be the primary diagnosis on the claim, and the documentation must back it up.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
Affected Codes
This policy does not list specific CPT, HCPCS, or ICD-10 codes in the policy document. The coverage determination applies to sterilization procedures broadly, with coverage status determined by clinical indication rather than a discrete code list. Your billing team should apply NCD 13 criteria when reviewing any claim involving hysterectomy, oophorectomy, orchidectomy, tubal ligation, or vasectomy on Medicare beneficiaries.
Work with your clinical documentation team and coding staff to ensure primary diagnosis coding accurately reflects the treated illness or injury—not the resulting sterilization outcome.
Documentation That Supports a Covered Claim Under NCD 13
Given how MAC claim review is structured under this policy, the following documentation elements are essential for defensible Medicare billing on these procedures:
- Pathology report confirming the diagnosis (tumor, cancer, diseased tissue) that necessitated the procedure
- Operative report with a clear clinical indication section that references the illness or injury being treated
- Pre-operative notes documenting the physician's clinical reasoning tied to diagnosis and treatment—not sterilization as an outcome or goal
- Primary diagnosis coding that leads with the illness or injury, not a sterilization or fertility-related code
If your practice is billing bilateral orchidectomy for prostate cancer, that cancer diagnosis needs to be front and center in every layer of documentation. The same applies to hysterectomy for uterine malignancy or oophorectomy for ovarian disease.
What Your Billing Team Should Do
| # | Action Item |
|---|---|
| 1 | Audit recent claims (within 90 days) for hysterectomy, oophorectomy, orchidectomy, tubal ligation, and vasectomy billed to Medicare. Confirm that each claim's primary diagnosis reflects a documented illness or injury—not a contraceptive indication or general health risk rationale. |
| 2 | Brief your clinical documentation team before the March 12, 2026 effective date. Surgeons and their documentation staff need to understand that "patient health risk from future pregnancy" is explicitly insufficient as a Medicare coverage justification under NCD 13. The operative note must connect the procedure to treating an identified illness or injury. |
| 3 | Flag any claims involving Medicare beneficiaries with intellectual or developmental disabilities where sterilization procedures are planned or recently performed. These claims receive heightened MAC scrutiny per the policy. Ensure pathological evidence of cancer or other treated illness is documented before billing. |
| 4 | Review your MAC's local coverage articles for any supplementary guidance tied to NCD 13. MACs have discretion to request additional documentation on these claims, and knowing your MAC's specific review patterns helps you respond faster to requests for records. |
| 5 | Update your pre-bill claim review checklist to add an NCD 13 flag for any sterilization-adjacent procedure codes on Medicare claims. This catches documentation gaps before submission rather than at the denial stage. |
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.